investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONS
Takeshi Egawa
1 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Yoichi Shinkai
RIKEN
Wako, Japan
Takeshi Egawa
University of Washington
Seattle, United States
Related projects
Wenwei Hu
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
Leukaemia
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Hematology and hematologic malignancies
Pathology
Zhe Li
IGF/IGF1R signaling in hematopoiesis and leukemogenesis
Leukaemia
Amy Paguirigan
Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia
Leukaemia
Paul B. Jacobsen
Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue
Leukaemia
James Y. Chen
Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating
Leukaemia
Daniel Fowler
Combination Gene Therapy and Th1/Th2 Therapy
Leukaemia
Hematology and hematologic malignancies
Alex Kentsis
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
Leukaemia
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies